Review
Published on 04 Mar 2022
3D Tissue-Engineered Vascular Drug Screening Platforms: Promise and Considerations
in Cardiovascular Biologics and Regenerative Medicine

- 16,796 views
- 31 citations
Review
Published on 04 Mar 2022
in Cardiovascular Biologics and Regenerative Medicine
Original Research
Published on 28 Feb 2022
in Cardiovascular Biologics and Regenerative Medicine
Editorial
Published on 28 Feb 2022
in Cardiovascular Biologics and Regenerative Medicine
Original Research
Published on 11 Feb 2022
in Cardiovascular Biologics and Regenerative Medicine
Review
Published on 11 Feb 2022
in Cardiovascular Biologics and Regenerative Medicine
Original Research
Published on 10 Feb 2022
in Cardiovascular Biologics and Regenerative Medicine
Review
Published on 10 Feb 2022
in Cardiovascular Biologics and Regenerative Medicine
Case Report
Published on 09 Feb 2022
in Cardiovascular Biologics and Regenerative Medicine
Original Research
Published on 03 Feb 2022
in Cardiovascular Biologics and Regenerative Medicine
Review
Published on 28 Jan 2022
in Cardiovascular Biologics and Regenerative Medicine
Original Research
Published on 27 Jan 2022
in Cardiovascular Biologics and Regenerative Medicine
Mini Review
Published on 21 Jan 2022
in Cardiovascular Biologics and Regenerative Medicine
Original Research
Published on 20 Jan 2022
in Cardiovascular Biologics and Regenerative Medicine
Original Research
Published on 20 Jan 2022
in Cardiovascular Biologics and Regenerative Medicine
Original Research
Published on 18 Jan 2022
in Cardiovascular Biologics and Regenerative Medicine
Original Research
Published on 17 Jan 2022
in Cardiovascular Biologics and Regenerative Medicine